StockData
Nasus Pharma Ltd logo

Nasus Pharma Ltd (NSRX) stock

NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30
$2.70+0.09 (+3.45%)

Close on Nov 18, 2026Market cap $24.34MP/E –Yield –

Nasus Pharma cash

Cash and short-term investments held at the end of each period.

Nasus Pharma's cash was $7.82M at Jun 30, 2026. For fiscal 2025 it was $1.24M, up 335.6% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.24M+335.6%
FY2024Dec 31, 2024$284.00K+47.2%
FY2023Dec 31, 2023$193.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$7.82M+768.7%
Q4 FY2025Dec 31, 2025$1.24M+540.9%
Q2 FY2025Jun 30, 2025$203.00K–
Q4 FY2024Dec 31, 2024$284.00K–
Q2 FY2024Jun 30, 2024$900.00K–
Q4 FY2023Dec 31, 2023$193.00K–

More Nasus Pharma figures

See a number that looks wrong?